Pontine demyelination as a late complication of resolved mild COVID-19 infection

  • Nouran Eshak
  • Mahmoud Abdelnabi
  • Roy Jacob
  • J. Drew Payne

Abstract

Previous case reports have demonstrated COVID-19 related neurotropism. Neural infection may result from trans-lamina cribrosa invasion that allows COVID-19 to reach the brain through the olfactory tract. A wide range of symptoms from headaches, anosmia, dysgeusia to neuropathy, encephalitis, cerebrovascular stroke, and rarely demyelination has been reported. Here, we report a case of pontine demyelination causing generalized weakness as a rare neurological complication in a COVID-19 survivor. Our case highlights that even mild and moderate COVID-19 infection can have late neurological sequelae.

Keywords: COVID-19, demyelination, neurological complications, corticosteroids

Downloads

Download data is not yet available.
Published
2021-10-22
How to Cite
Eshak, N., Abdelnabi, M., Jacob, R., & Payne, D. (2021). Pontine demyelination as a late complication of resolved mild COVID-19 infection. The Southwest Respiratory and Critical Care Chronicles, 9(41), 60-63. https://doi.org/10.12746/swrccc.v9i41.947